Cordance Medical Inc.
Mountain View, CA
- UEI
- X7NLMYNHPF66
- CAGE
- 89K69
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 2483 Old Middlefield Way #120, Mountain View, CA 94043, USA
- Website
- cordancemedical.com
- Founded
- 2018
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Similar vendors
About the company
Cordance Medical Inc. is a Mountain View, California-based for-profit corporate entity focused on developing innovative medical technologies in the neurological and cancer diagnostic space. Registered in SAM.gov since December 2018, the company specializes in developing advanced focused ultrasound systems for non-invasive medical diagnostic and therapeutic applications, with a particular emphasis on brain tumor detection and treatment technologies. The company appears to be a research-driven medical technology organization that leverages sophisticated ultrasound and microbubble techniques to address critical challenges in brain tumor diagnostics and potential treatment delivery.
The company has secured multiple significant federal grants from agencies like the National Cancer Institute and the National Science Foundation, predominantly targeting breakthrough medical technologies for brain tumor diagnostics and blood-brain barrier manipulation. Their primary research focus involves developing the "NeuroAccess" system, a focused ultrasound technology designed to temporarily and safely open the blood-brain barrier to enable liquid biopsies and improve brain tumor detection and molecular characterization. Specifically, their recent federal grants totaling approximately $2.4 million have supported projects such as developing a non-invasive sonobiopsy technique for brain tumors, optimizing focused ultrasound methods for detecting circulating free DNA, and creating transcranial dynamic focused ultrasound systems for potential therapeutic agent delivery. These grants, ranging from $399,358 to $999,125, demonstrate the company's commitment to innovative medical research with potential transformative implications for brain tumor patient management and diagnostic capabilities.
Quick answers
Is Cordance Medical Inc. registered in SAM.gov?
Yes. Cordance Medical Inc.'s SAM.gov registration is active through September 7, 2027.
What is Cordance Medical Inc.'s most recent federal award?
Cordance Medical Inc.'s most recent federal grant award is Neuroaccess: a focused ultrasound system for sonobiopsy of the brain (R44CA298351), from National Cancer Institute (NIH), on September 11, 2025.
On GovTribe
See Cordance Medical Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors